Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel metal-free asymmetric deuteration method using D2O. High enantioselectivity for pharma intermediates. Cost-effective supply chain solution.
Novel scalable route for 4-(1-cyclopropyl-1H-indol-3-yl) derivatives. High purity, optimized cyclopropylation for third-generation EGFR inhibitors.
Patent CN118125939B reveals metal-free diamination. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable high-purity processes.
Novel iridium-catalyzed C-H bond boronation method offers high selectivity and yield for pharmaceutical intermediate manufacturing without strong acids.
Patent CN114031552A reveals a metal-free quinoline synthesis using DMSO as a carbon source, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel preparation method for 4-(1-cyclopropyl-1H-indol-3-yl)-N-phenylpyrimidin-2-amine derivatives offering high purity and scalable industrial application for third-generation EGFR inhibitors.
Patent CN113444108B reveals a novel organocatalytic route for 1,4-sulfur bridge polycyclic compounds, offering high stereoselectivity and mild conditions for API manufacturing.
Patent CN105175375A reveals high-yield benzopyrone synthesis. Discover cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Novel patent CN120774805A route for irinotecan intermediates. Higher yield, simplified steps, reliable pharmaceutical intermediate supplier for global scale-up.
High-yield synthesis of azaspiro compounds via Pt-catalysis. Cost-effective pharmaceutical intermediate manufacturing with scalable processes.
Patent CN105777852A reveals optimized Deflazacort synthesis yielding 68% purity. Reduces steps for cost effective pharmaceutical intermediates manufacturing supply chain.
Novel synthesis route for methocarbamol impurity E avoiding phosgene. High yield scalable process for pharmaceutical intermediate supply chain stability and cost efficiency.
Patent CN107674085B reveals a novel Lewis acid-catalyzed route for 1,5-epoxy-benzazepines, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN119306645A reveals advanced pyrrolamide synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable, high-yield processes.
Advanced synthesis of 2-chloro-5-thiophenecarboxylic acid via chlorination and oxidation. High-yield route for Razaxaban intermediates with reduced environmental impact.
Discover the novel TiCl4-catalyzed synthesis of N-heteroatom polycyclic indolizines. A cost-effective, scalable route for high-purity pharmaceutical intermediates.
Patent CN121181461A details a high-yield acetic acid catalyzed route for pyrrolidone intermediates, offering significant cost reduction and supply reliability for API manufacturing.
Patent CN111704555A reveals a safer continuous flow method for 4-methoxy-2-nitroaniline. Achieve >99% purity and reduced costs in omeprazole intermediate manufacturing.
Novel synthesis of Erlotinib HCl via 3,4-dihydroxybenzaldehyde avoids demethylation steps, offering cost-effective industrial scale-up for pharmaceutical intermediates.
Patent CN113292563B reveals a mild Pd-catalyzed C-H bisacetoxylation method for pyrrolo[2,3-d]pyrimidines, offering reliable pharmaceutical intermediate supply and cost reduction.